The Klinique Medical Clinic Public Company Limited (KLINIQ.BK)
THB 30.0
(0.0%)
THB 30.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 401.17 Million | 407.95 Million | 238.56 Million | 248.25 Million | 208.92 Million | 153.51 Million |
| Net Income | 288.61 Million | 205.48 Million | 129.25 Million | 144.69 Million | 115.46 Million | 16.76 Million |
| Depreciation & Amortization | 194.6 Million | 142 Million | 81.19 Million | 77.31 Million | 74.52 Million | 60.33 Million |
| Deferred income taxes | 61.6 Million | 40.7 Million | 20.59 Million | 20.9 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 245.34 Million | 276.53 Million | 220.06 Million | 199.21 Million | 967.14 Million | 885.34 Million |
| Other non-cash items | 84.99 Million | -256.77 Million | -188.91 Million | -171.8 Million | -828.85 Million | -720.13 Million |
| Investing Cash Flow | -436.63 Million | -1.22 Billion | -51.37 Million | -24.75 Million | -188.62 Million | -109.98 Million |
| Investments in PPE | -367.11 Million | -226.95 Million | -74.03 Million | -148.54 Million | -138.84 Million | -73.42 Million |
| Acquisitions | 479.55 Thousand | - | 2.6 Million | 3.75 Million | 30.22 Million | 3.44 Million |
| Investment purchases | -70 Million | -1 Billion | -22.6 Million | -5 Million | - | - |
| Sales/Maturities of investments | 10 Million | - | 20 Million | 1.24 Million | 20 Million | - |
| Other Investing Activities | -10 Million | 615.63 Thousand | 22.66 Million | 123.79 Million | -100 Million | -40 Million |
| Financing Cash Flow | -320.5 Million | 1.2 Billion | -120.56 Million | -316.04 Million | -1.85 Million | -1.3 Million |
| Debt repayment | -89.5 Million | -63.38 Million | -27.62 Million | -29.78 Million | -1.85 Million | -1.3 Million |
| Dividends payments | -230.99 Million | -153.2 Million | -80 Million | -299.2 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1.47 Billion | - | - | - | - |
| Other Financing Activities | -89.5 Million | -46.39 Million | -12.94 Million | 12.94 Million | -1.00 | - |
| Accounts receivables | -4.82 Million | -1.41 Million | -590.47 Thousand | -434.87 Thousand | 1.05 Million | -528.52 Thousand |
| Accounts payables | 52.63 Million | 37.18 Million | 14.93 Million | 7.21 Million | 33.21 Million | 6.41 Million |
| Inventory | -70.99 Million | -35.5 Million | 18.52 Million | -36.46 Million | -4.55 Million | 25.98 Million |
| Other working capital | 268.52 Million | 276.26 Million | 187.19 Million | 228.9 Million | 937.43 Million | 853.47 Million |
| Cash at beginning of period | 464.44 Million | 75.9 Million | 9.28 Million | 101.83 Million | 83.37 Million | 41.14 Million |
| Cash at end of period | 108.48 Million | 464.44 Million | 75.9 Million | 9.28 Million | 101.83 Million | 83.37 Million |
| Capital Expenditure | -367.11 Million | -226.95 Million | -74.03 Million | -148.54 Million | -138.84 Million | -73.42 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -355.96 Million | 388.53 Million | 66.62 Million | -92.54 Million | 18.45 Million | 42.23 Million |
| Free Cash Flow | 34.06 Million | 181 Million | 164.52 Million | 99.7 Million | 70.08 Million | 80.08 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 74.11 Million | 75.27 Million | 77.95 Million | 288.61 Million | 70.95 Million | 70.64 Million |
| Depreciation & Amortization | 68.39 Million | 61.53 Million | 54.83 Million | 194.6 Million | 49.6 Million | 46.94 Million |
| Deferred income taxes | 3.07 Million | -3.07 Million | 10.89 Million | 61.6 Million | 18.47 Million | 15.64 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 61.54 Million | 125.08 Million | -34.48 Million | 245.34 Million | 90.32 Million | 61.8 Million |
| Other non-cash items | 87.41 Million | -16.18 Million | 86.15 Million | 84.99 Million | -49.66 Million | -84.11 Million |
| Investing Cash Flow | 52.2 Million | 156 Million | -148.72 Million | -436.63 Million | -82.37 Million | -116.35 Million |
| Investments in PPE | -157.39 Million | -151.64 Million | -88.72 Million | -367.11 Million | -82.38 Million | -116.27 Million |
| Acquisitions | 10.12 Million | 7.65 Million | 935.00 | 479.55 Thousand | 8131.00 | 470.49 Thousand |
| Investment purchases | - | - | -60 Million | -70 Million | - | -10 Million |
| Sales/Maturities of investments | 199.48 Million | 300 Million | 54.05 Million | 10 Million | - | 9.52 Million |
| Other Investing Activities | 215.11 Million | 313.86 Million | -54.05 Million | -10 Million | -397.3 Thousand | -80.19 Thousand |
| Financing Cash Flow | -192.47 Million | -31.69 Million | -22.48 Million | -320.5 Million | -142.55 Million | -131.86 Million |
| Debt repayment | -27.47 Million | -31.69 Million | -22.48 Million | -89.5 Million | -21.55 Million | -21.86 Million |
| Dividends payments | -164.99 Million | - | - | -230.99 Million | -120.99 Million | -109.99 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -27.47 Million | - | - | - | - | -21.86 Million |
| Accounts receivables | -587.88 Thousand | 2.13 Million | 461.89 Thousand | -4.82 Million | -3.12 Million | -2.3 Million |
| Accounts payables | -16.43 Million | 25.12 Million | 11.71 Million | 52.63 Million | 65.75 Million | -19.79 Million |
| Inventory | -31.75 Million | -35.86 Million | -25.49 Million | -70.99 Million | -32.56 Million | 309.58 Thousand |
| Other working capital | 110.32 Million | 133.69 Million | -21.16 Million | 268.52 Million | 60.25 Million | 83.58 Million |
| Cash at beginning of period | 343.75 Million | 108.48 Million | 218.21 Million | 464.44 Million | 302.31 Million | 463.59 Million |
| Cash at end of period | 312.46 Million | 343.75 Million | 108.48 Million | 108.48 Million | 218.21 Million | 302.31 Million |
| Capital Expenditure | -157.39 Million | -151.64 Million | -88.72 Million | -367.11 Million | -82.38 Million | -116.27 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -31.28 Million | 235.27 Million | -109.72 Million | -355.96 Million | -84.1 Million | -161.27 Million |
| Free Cash Flow | -48.42 Million | -40.68 Million | -27.24 Million | 34.06 Million | 58.43 Million | -29.33 Million |
300031
301190
SGRO
PCSA
0SAY
KOHINOOR